Deciphering the role of GPCRs in obesity pathology for drug development

FHS
March 6, 2024
1:25 am

Announcing a new publication for Acta Materia Medica journal. G protein-coupled receptors (GPCRs) are important, potential drug targets for the treatment of metabolic disorders, such as obesity.

John Snow Labs Launches API Endpoints for Medical Language Models

What You Should Know: – John Snow Labs, a leader in AI for healthcare announced the release of API endpoints for its medical language models

August 14, 2024

TC BioPharm secures European patent for cancer treatment

The development marks a significant milestone for the company as it aligns with TCBP’s commercial strategy in Europe. Credit: Lightspring/Shutterstock. TC BioPharm (TCBP) has announced

August 29, 2024

Atezolizumab by F. Hoffmann-La Roche for Oropharyngeal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.